Abstract
Enchondroma of a hand is a common benign tumor. Enchondroma commonly presents as a pathological fracture associated with pain, deformity, and swelling. Dysfunction of the fingers occurs as a result of the fracture. Curettage is the mainstay of surgical treatment for enchondroma.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Enchondroma of a hand is a common benign tumor. Enchondroma commonly presents as a pathological fracture associated with pain, deformity, and swelling. Dysfunction of the fingers occurs as a result of the fracture. Curettage is the mainstay of surgical treatment for enchondroma. The bone defect is then filled with bone chips and bone substitutes, such as calcium phosphate bone cement (CPC) and hydroxyapatite [1, 4–8]. We treated enchondroma of the 5th middle phalanx by curettage and filled the defect with CPC. However, fracture of CPC was caused by slight injury. Therefore, we removed this broken CPC and filled the defect with autologous bone graft. After 1 year, patient had achieved good functional and radiographic results.
A case report
A 14-year-old girl developed pain and swelling of the ulnaris of her right hand that persisted for one month. When she presented to our institution, pain had become severe. She had full range of motion of all fingers. Radiograph showed rarefaction of the bone and a radiolucent lesion in the 5th middle phalanx (Fig. 1). The cortex was thinned. We diagnosed enchondroma and performed curettage of the intramedullary canal, then filled the defect with CPC (biopex; Mitsubishi Materials Corp. Tokyo. Japan).
We approached the lesion from the dorsal side. The bone cortex was fenestrated and tumor was curetted. The tumor was like sorbet, in places was found calcification. Part of the bone defect was filled with CPC (Fig. 2). Postoperatively, she returned to playing basketball, because she had regained good hand function.
Thirty-one months postoperatively, she ran into another player while playing basketball. When she presented to our institution again, she complained of pain in the ulnaris of her right hand and the little finger appeared crossed. Radiograph showed fracture of her 5th middle phalanx that was filled with CPC (Fig. 3). She was admitted to our institution for further surgery.
A longitudinal skin incision was made over the 5th middle phalanx. Rarefaction of the cortical bone was remarkable. CPC was curetted by high-speed burr drilling, and the defect was filled with morselized autologous bone from the iliac crest. The 5th middle phalanx was fixed by external fixation with the cap of injection needle and C-wire (Zimmer. Tokyo. Japan.) (Fig. 4). Stability of bone was obtained. 6 weeks postoperatively, the external fixation was removed. Three months postoperatively, radiograph showed bone healing (Fig. 5). One year after the second operation, she had regained good functional results and returned to playing basketball.
Discussion
Enchondromas are predominantly seen in the skeleton of the hand and are the most frequent osseous tumors of the hand. In treating enchondromas, surgeons aim to prevent pathological fracture and remove the tumor. There are numerous reports presenting results after operative treatment of enchondromas [1, 4–8]. Enchondromas are treated by curettage and the bone defect is then usually filled with morselized autologous bone chip from the iliac crest or with an allograft. Recently, bone substitutes, such as calcium phosphate bone cement (CPC) and hydroxyapatite, have also been used instead of autologous or allogenic bone grafts [1, 5, 6, 8].
It is well-known that a fresh fracture is surrounded by hematoma, and this hematoma will be invaded by multi-potent mesenchymal cells which differentiate into osteoblasts, a pre-requisite for bone healing [7]. Therfeore, curettage has recently become the mainstay of surgical treatment for enchondroma. However, patients who have undergone curettage alone must restrict their activity with the operated hand. We treated our case by curettage and part of the bone defect was filled with CPC during the first operation, because this technique provides immediate mechanical stability and allows early mobilization and force transmission around the adjacent joint [8].
CPC offers advantages over polymethylmethacrylate (PMMA), such as eventual osseous resorption and euthermic consolidation reaction. In vitro, comparing the strength of CPC with that of PMMA in subchondral bone defects, CPC is stronger than PMMA [2]. Regarding bone conduction, CPC is inferior to beta tricalcium phosphate (beta-TCP). Beta-TCP appeared to be a bone replacement material with optimal biocompatibility, resorption characteristics and bone conduction properties for clinical use [3]. However, bone conduction dose not occur with CPC.
Yasuda et al. reported outcome of treating enchondroma of the hand by curettage and CPC grafting [8]. The average follow-up period was 41 months that study. They considered CPC a good candidate for treatment of enchondroma of the hand.
The primary stability of CPC is very strong, however, there is no bone conduction of CPC. This is a limitation of using CPC as a bone substitute. Therefore, in our case, we think fracture of CPC was caused by a slight injury sustained 31 months post-operatively.
References
Bickels J, Wittig JC, Kollender Y, Kellar-Graney K, Mansour KL, Meller I, Malawer MM (2002) Enchondromas of the hand: treatment with curettage and cemented internal fixation. J Hand Surg 27A(5):870–875
Crawford K, Berrey BH, Pierce WA, Welch RD (1998) In vitro strength comparison of hydroxyapatite cement and polymethylmethacrylate in subchondral defects in caprine femora. J Orthop Res 16(6):715–719
Gaasbeek RD, Toonen HG, van Heerwaarden RJ, Buma P (2005) Mechanism of bone incorporation of beta-TCP bone substitute in open wedge tibial osteotomy in patients. Biomaterials 26(33):6713–6719
Goto T, Yokokura S, Kawano H, Yamamoto A, Matsuda K, Nakamura K (2002) Simple curettage without bone grafting for enchondromata of the hand: with special reference to replacement of the cortical window. J Hand Surg 27B(5):446–451
Joosten U, Joist A, Frebel T, Walter M, Langer M (2000) The use of an in situ curing hydroxyapatite cement as an alternative to bone graft following removal of enchondroma of the hand. J Hand Surg 25B(5):288–291
Kita K, Masada K, Yasuda M, Takeuchi E (2003) Enchondroma protuberans of the phalanx: a case report. J Hand Surg 28A(6):1052–1054
Tordai P, Hoglund M, Lugnegard H (1990) Is the treatment of enchondroma in the hand by simple curettage a rewarding method? J Hand Surg 15B(3):331–334
Yasuda M, Masada K, Takeuchi E (2006) Treatment of enchondroma of the hand with injectable calcium phosphate bone cement. J Hand Surg 31A(1):98–102
Conflict of interest statement
No funds were received in support of this study.
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Naito, K., Obayashi, O., Mogami, A. et al. Fracture of the calcium phosphate bone cement which used to enchondroma of the hand: a case report. Eur J Orthop Surg Traumatol 18, 405–408 (2008). https://doi.org/10.1007/s00590-008-0321-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-008-0321-x